Johnson & Johnson has become even more profitable with its Risperdal drug. While Risperdal has helped many schizophrenia patients with symptom management, Risperdal was only FDA approved for serious psychotic conditions. More and more, Risperdal has been used to treat conditions besides schizophrenia. Doctors are giving Risperdal to control behavioral disorders in elderly patients with dementia and Alzheimer's disease, as well as in children with conduct disorders.
J&J announced on April 10, 2003 that the company would be sending out letters to thousands of U.S. physicians to advise them of the possible increased risk of stroke in elderly Risperdal patients. The Risperdal effects included both strokes and stroke- like events, such as blood clots and hemorrhages, affecting especially elderly Risperdal patients. J&J said that in addition to the thousands of letters being sent to health care professionals warning of the effects of Risperdal, an update to the Risperdal label would be made.
The clinical trials testing Risperdal in Alzheimer patients involved 764 Risperdal patients in which 29 cases of stroke and stroke-related events were seen, in addition to four deaths. The 29 Risperdal stroke occurrences accounted for 4% of the study, compared to just 2% in the placebo group and one death. Larry Sasich, a pharmacist and research analyst for Public Citizen thinks that, "The Risperdal label clearly states that there is no evidence this drug is safe or effective in treating dementia, and it looks like doctors are hurting people by prescribing it for this condition."
While the Risperdal company has become very profitable, patients have suffered death, strokes, stroke-like events like blood clots and hemorrhages, neuroleptic malignant syndrome, in addition to many other effects. Although the company has sent out Risperdal warning letters and plans on making Risperdal package-insert labeling changes, the company had already warned physicians of the Risperdal risks in October 2002, six months earlier than in the U.S. citing 37 reports of stroke or related events, including 16 deaths.
A Risperdal attorney can help Risperdal patients that have suffered serious Risperdal side effects determine if they may have a strong case. Children prescribed strong antipsychotic drugs like Risperdal risk severe side effects that could last a lifetime. Since there have not been any studies determining if Risperdal is safe for use in children, parents with children that have suffered from the serious effects of Risperdal are wondering why it is being prescribed to them for reasons other than schizophrenia or serious mental illnesses in addition to there being limited information on its effect on children.
For more information regarding Risperdal Side Effects, Contact our Risperdal Side Effect Attorneys for a FREE Evaluation! CLICK HERE!